Global Custom Market Research Reports Provider Company

phone

Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Flexion Therapeutics Inc (Flexion) is a pharmaceutical company that develops and commercializes pain therapies. The companys products comprise FX006, FX007, and FX005. Its FX005 is a p38 mitogen-activated protein, kinase inhibitor that contains both analgesic and anti-inflammatory properties. It provides FX006, an injectable, intra-articular, sustained release drug to provide long lasting, local analgesia. The company offers FX007, a preclinical, small molecule TrkA receptor antagonist designed to treat post-operative pain. It offers anti-inflammatory and analgesic therapies for osteoarthritis. Flexion is headquartered in Burlington, Massachusetts, the US.

Flexion Therapeutics Inc Key Recent Developments

Dec 12,2017: Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as CMO
Dec 11,2017: Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as Chief Medical Officer
Nov 06,2017: Flexion Therapeutics Reports Third-Quarter 2017 Financial Results and Recent Business Highlights
Aug 08,2017: Flexion Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights
Jun 28,2017: Flexion Therapeutics appoints new senior vice president, general counsel and secretary

This comprehensive SWOT profile of Flexion Therapeutics Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Flexion Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData


Section 1 - About the Company

Flexion Therapeutics Inc - Key Information
Flexion Therapeutics Inc - Overview
Flexion Therapeutics Inc - Key Employees
Flexion Therapeutics Inc - Key Employee Biographies
Flexion Therapeutics Inc - Key Operational Heads
Flexion Therapeutics Inc - Major Products and Services
Flexion Therapeutics Inc - History
Flexion Therapeutics Inc - Company Statement
Flexion Therapeutics Inc - Locations And Subsidiaries
Flexion Therapeutics Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Flexion Therapeutics Inc - Business Description
Flexion Therapeutics Inc - Corporate Strategy
Flexion Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Flexion Therapeutics Inc - Strengths
Flexion Therapeutics Inc - Weaknesses
Flexion Therapeutics Inc - Opportunities
Flexion Therapeutics Inc - Threats
Flexion Therapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Flexion Therapeutics Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Flexion Therapeutics Inc, Key Information
Flexion Therapeutics Inc, Key Ratios
Flexion Therapeutics Inc, Share Data
Flexion Therapeutics Inc, Major Products and Services
Flexion Therapeutics Inc, History
Flexion Therapeutics Inc, Key Employees
Flexion Therapeutics Inc, Key Employee Biographies
Flexion Therapeutics Inc, Key Operational Heads
Flexion Therapeutics Inc, Other Locations
Flexion Therapeutics Inc, Subsidiaries
Flexion Therapeutics Inc, Key Manufacturing facilities
Flexion Therapeutics Inc, Key Competitors
Flexion Therapeutics Inc, SWOT Analysis
Flexion Therapeutics Inc, Ratios based on current share price
Flexion Therapeutics Inc, Annual Ratios
Flexion Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Flexion Therapeutics Inc, Performance Chart
Flexion Therapeutics Inc, Ratio Charts

The global market size of Lateral Flexion Weight Training Station is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million

View Report

Flexion Therapeutics Inc (Flexion) is a pharmaceutical company that develops and commercializes pain therapies. The companys products comprise FX006, FX007, and FX005. Its FX005 is a p38 mitogen-activated protein, kinase

View Report

Flexion Therapeutics Inc (Flexion) is a pharmaceutical company that develops and commercializes pain therapies. The companys products comprise FX006, FX007, and FX005. Its FX005 is a p38 mitogen-activated protein, kinase

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports